Overview

Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
Study will determine whether patients with schizophrenia or schizoaffective disorder can be helped to quit smoking safely while using varenicline and receiving smoking cessation counseling.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Varenicline